医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK1593 医美概念股

未开盘 12-16 16:00:00

1,144.564

-19.700

-1.69%

最高1,168.670	最低1,119.186	成交量7,336万
今开1,161.420	昨收1,164.264	日振幅4.25%
总市值0.00	流通市值0.00	总股本0.00
成交额11.93亿	换手率--	流通股本0.00
市净率1.724849	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":1144.5643,"timestamp":1765872498184,"preClose":1164.2644,"halted":0,"volume":73355361,"delay":0,"changeRate":-0.016921,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-19.700073,"latestTime":"12-16 16:00:00","open":1161.4204,"high":1168.6697,"low":1119.1855,"amount":1193289394,"amplitude":0.042502,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765935000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1765848600000,1765857600000],[1765861200000,1765872000000]],"pbRate":1.724849,"peRate":24.93058,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK1593","defaultTab":"news","newsList":[{"id":"2591988977","title":"甘露特钠迎转机，复星医药拟控股绿谷医药推进其上市后临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2591988977","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591988977?lang=zh_cn&edition=full","pubTime":"2025-12-16 17:52","pubTimestamp":1765878774,"startTime":"0","endTime":"0","summary":"12月15日，复星医药宣布，控股子公司复星医药产业与绿谷（上海）医药科技有限公司（“绿谷医药”）及其现有相关股东共同签订相关投资协议，拟出资约14.12亿元控股收购绿谷医药。本次收购完成后，绿谷医药将成为复星医药控股子公司，其核心药品甘露特钠胶囊也将纳入复星医药创新药品管线，主要用于治疗轻度至中度阿尔茨海默病（AD）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512163593128594.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512163593128594.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0183","BK1574","BK0060","BK0196","BK1161","BK1515","159938","BK1191","09939","BK0239","BK0096","02196","BK0187","BK0175","BK0188","600196","BK0028","BK0012","BK1593"],"gpt_icon":0},{"id":"2591983722","title":"复星医药旗下复星杏脉AI-ROSE系统亮相2025国际机器人支气管镜会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2591983722","media":"复星医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591983722?lang=zh_cn&edition=full","pubTime":"2025-12-16 17:44","pubTimestamp":1765878287,"startTime":"0","endTime":"0","summary":"2025年12月12日至14日，由中国人体健康科技促进会、北京慢性病防治与健康教育研究会共同主办，上海市胸科医院协办的“2025国际机器人支气管镜会议”在上海市举办。会议期间，复星医药旗下复星杏脉携AI-ROSE智能辅助分析系统解决方案参会，同时现场还展出了数字显微图像荧光扫描系统等高端硬件设备，实现从软件智能分析到硬件数字化的完整技术闭环，为呼吸介入诊疗树立新范式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216182103a6a926ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216182103a6a926ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1593","02196","BK1515"],"gpt_icon":0},{"id":"2591607496","title":"集采落地后的国产正畸“黑马”：美立刻突然停服，万名患者权益保障成焦点","url":"https://stock-news.laohu8.com/highlight/detail?id=2591607496","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591607496?lang=zh_cn&edition=full","pubTime":"2025-12-16 17:04","pubTimestamp":1765875862,"startTime":"0","endTime":"0","summary":"集采政策实施不到一年，国产隐形正畸“黑马”宣告退场，上万名患者治疗面临中断风险。2025年12月初，国产隐形正畸品牌美立刻宣布因“技术和运营问题”无法继续提供服务。作为2025年正畸集采落地后，首个因运营承压退出市场的国产主流品牌，美立刻的停服事件迅速在行业内引发连锁反应，包括全国1800余个城市的万名在治患者及近5万家合作门诊。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512163593077930.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512163593077930.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1100","06699","BK1587","BK1593"],"gpt_icon":0},{"id":"2591607815","title":"复星医药收购绿谷医药，阿尔兹海默病患者看到曙光？","url":"https://stock-news.laohu8.com/highlight/detail?id=2591607815","media":"读懂财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591607815?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:49","pubTimestamp":1765874940,"startTime":"0","endTime":"0","summary":"　　“阿尔茨海默病药物研发的“死亡谷”里，一款曾被誉为国产创新药希望、又深陷科学争议的明星药物，正在等待它的救赎。”　　12月15日，复星医药宣布收购绿谷医药，其核心产品甘露特钠胶囊也将纳入复星医药创新药品管线。凭借着深厚的全球研发能力和中枢神经领域日益完善的创新药械矩阵，复星医药能否让这款命运多舛的药物重获新生，从而破解现有阿尔茨海默病治疗药物疗效欠佳的困局，成为行业关注的焦点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2025-12-16/doc-inhaysim8510706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK0188","BK0012","600196","BK0028","BK1161","BK0187","BK1515","BK0175","02196","BK0096","BK1593","BK0239","159938","BK1191","BK0196","09939","BK0060","BK0183"],"gpt_icon":0},{"id":"2591797983","title":"每日卖空追踪 | 时代天使 12月16日卖空量成交3.38万股，卖空比例为8.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591797983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591797983?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873834,"startTime":"0","endTime":"0","summary":"时代天使北京时间12月16日，跌0.82%，卖空量成交3.38万股，较上一交易日减少48.63%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163624a6a8b87e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163624a6a8b87e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1587","BK1100","BK1583","06699"],"gpt_icon":0},{"id":"2591706983","title":"每日卖空追踪 | 昊海生物科技 12月16日卖空量成交1.67万股，卖空比例为4.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591706983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591706983?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873834,"startTime":"0","endTime":"0","summary":"昊海生物科技北京时间12月16日，跌3.72%，卖空量成交1.67万股，较上一交易日减少68.96%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163625a6a8b887&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163625a6a8b887&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1593","06826"],"gpt_icon":0},{"id":"2591898308","title":"每日卖空追踪 | 复星医药 12月16日卖空量成交200.5万股，卖空比例为13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591898308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591898308?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873826,"startTime":"0","endTime":"0","summary":"复星医药北京时间12月16日，跌5.81%，卖空量成交200.5万股，较上一交易日增加400.62%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163407a4519ed1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163407a4519ed1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1515","BK1191","02196"],"gpt_icon":0},{"id":"2591983747","title":"昊海生物科技12月16日遭主力抛售33.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591983747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591983747?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:15","pubTimestamp":1765872955,"startTime":"0","endTime":"0","summary":"12月16日, 昊海生物科技股价跌3.72%，报收24.88元，成交金额942.7万元，换手率0.98%，振幅6.81%，量比2.09。昊海生物科技今日主力资金净流出33.5万元，上一交易日主力净流出81.1万元。该股近5个交易日下跌7.23%，主力资金累计净流出77.9万元；近20日主力资金累计净流入344.0万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162155a6a8a7ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162155a6a8a7ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06826","BK1593"],"gpt_icon":0},{"id":"2591983082","title":"又一家“司美格鲁肽”申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2591983082","media":"潜沉药研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591983082?lang=zh_cn&edition=full","pubTime":"2025-12-16 14:20","pubTimestamp":1765866029,"startTime":"0","endTime":"0","summary":"12 月 11 日，CDE 官网显示，正大天晴子公司连云港润众制药司美格鲁肽注射液申报上市，注册分类为 3.3 类。截图来源：CDE 官网正大天晴“司美格鲁肽”于 2023 年 6 月首次申请临床，8 月获批临床，并在 10 月首次启动临床。Insight 数据库显示，目前国内已有 10 款国产司美格鲁肽申报上市，分别来自正大天晴、石药集团、复星万邦、倍特药业、惠升生物、中美华东、联邦制药、九源基因、丽珠集团、齐鲁制药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216142929a4512245&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216142929a4512245&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","02196","BK1191","BK1515"],"gpt_icon":0},{"id":"2591676206","title":"同仁堂回应磷虾油涉嫌造假；复星医药14.12亿元收购绿谷医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2591676206","media":"21世纪经济报道","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591676206?lang=zh_cn&edition=full","pubTime":"2025-12-16 07:34","pubTimestamp":1765841653,"startTime":"0","endTime":"0","summary":"资本市场复星医药：控股子公司拟出资14.12亿元投资绿谷医药12月15日，复星医药公告称，公司控股子公司复星医药产业拟出资共计14.12亿元投资绿谷医药，包括受让部分股权和认缴新增注册资本。完成后，公司将通过复星医药产业及SPV合计持有绿谷医药53%的股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216073706a6a6ce59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216073706a6a6ce59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","00867","BK1574","09939","BK1515","BK1161","02196","02565","BK1191"],"gpt_icon":0},{"id":"2591642540","title":"复星医药14亿入局阿尔茨海默病 缘何选择押注绿谷“九期一”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2591642540","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591642540?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:14","pubTimestamp":1765808084,"startTime":"0","endTime":"0","summary":"近日，阿尔茨海默病药物赛道异常热闹。在两款近年来最具突破性的阿尔茨海默病对因治疗药物——仑卡奈单抗注射液和多奈单抗注射液双双入选我国首版《商业健康保险创新药品目录》后，争议与机遇并存的国产阿尔茨海默病药物甘露特钠，在面临停产、换证危机之际，迎来了中国医药巨头复星医药的入局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512153592045515.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512153592045515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1593","BK0028","BK0096","BK0196","600196","02196","BK0060","BK1515","BK0175","BK0187","BK0188","BK0183","BK1191","BK0239","BK0012"],"gpt_icon":0},{"id":"2591264308","title":"康哲药业(00867)：创新药口服小分子JAK1抑制剂Povorcitinib 纳入突破性治疗品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2591264308","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591264308?lang=zh_cn&edition=full","pubTime":"2025-12-15 19:49","pubTimestamp":1765799362,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 发布公告，集团旗下德镁医药有限公司拥有相关许可权利的创新口服JAK1抑制剂povorcitinib已获中国国家药品监督管理局药品评审中心批准纳入突破性治疗品种名单，拟定适应症为成人患者非节段型白癜风。Povorcitinib目前正在海外若干国家进行非节段型白癜风、中重度化脓性汗腺炎和结节性痒疹的3期临床试验。本次该产品获纳入突破性治疗药物品种名单，有望加速其在中国大陆的研发与审评进程。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381734.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00867","BK1574","SG9999015952.SGD","IE00BMCWC346.EUR","BK1191","IE00BVYPNQ40.USD","SG9999015945.SGD","SG9999004220.SGD","LU2488822045.USD","IE00BYV24P56.USD","IE00BVYPNP33.GBP","SG9999015978.USD","IE00BGHQDM52.EUR","159992","06978","SG9999015986.USD","BK1593","BK1161"],"gpt_icon":0},{"id":"2591648625","title":"争议药物\"九期一\"获新生？复星医药14亿元收购绿谷医药重启临床与商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2591648625","media":"蓝鲸财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591648625?lang=zh_cn&edition=full","pubTime":"2025-12-15 18:51","pubTimestamp":1765795877,"startTime":"0","endTime":"0","summary":"此次收购案后，复星医药方面表示，甘露特钠胶囊重新开展商业化生产和销售前，还需补充完成目前尚在开展的上市后确证性临床试验并获得国家药品审评部门批准。本次收购完成后，复星医药将携绿谷医药团队在药品审评部门的指导下，有序严谨推进上市后确证性临床试验，以期尽快实现获批；并适时开展相关适应症的国际多中心临床试验，惠及更多阿尔茨海默病患者。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1765795546434638047","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0183","BK0175","BK0188","BK1191","BK1515","BK0028","BK0187","BK0196","BK0060","BK1593","BK0012","600196","09939","BK1161","02196","BK0096","BK1574","BK0239","159938"],"gpt_icon":1},{"id":"2591612068","title":"复星医药：控股子公司拟出资14.12亿元投资绿谷医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2591612068","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591612068?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:43","pubTimestamp":1765791813,"startTime":"0","endTime":"0","summary":"每经AI快讯，12月15日，复星医药(600196.SH)公告称，公司控股子公司复星医药产业拟出资共计14.12亿元投资绿谷医药，包括受让部分股权和认缴新增注册资本。完成后，公司将通过复星医药产业及SPV合计持有绿谷医药53%的股权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512153591807093.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512153591807093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1593","BK1191","BK0012","BK0096","BK1574","BK1515","09939","BK0060","BK0188","BK0175","BK0239","BK0196","600196","BK0183","BK0187","BK0028","02196","159938","BK1161"],"gpt_icon":0},{"id":"2591625600","title":"3家药企因下游合作方“不合规交易行为”公开致歉","url":"https://stock-news.laohu8.com/highlight/detail?id=2591625600","media":"一拾药讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591625600?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:35","pubTimestamp":1765791351,"startTime":"0","endTime":"0","summary":"近日，河南省医药集中采购平台公布了3家药企发布的致歉声明。分别为哈尔滨誉衡制药、吉林四环制药、珠海经济特区粤康医药三家企业的公开致歉声明，原因均为其配送商或代理商存在不合规交易行为。珠海经济特区粤康医药则因其注射用头孢呋辛钠的代理商违规，被预评为“特别严重失信”。这一现象反映出，在医药招采信用评价制度下，药企对合作方的合规管理已与其自身信用直接挂钩，下游一旦违规，药企也难逃责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215183743a44dbf01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215183743a44dbf01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","01477","BK1161","BK1191","09939","00460","BK1574","BK1600","BK1515"],"gpt_icon":0},{"id":"2591649590","title":"每日卖空追踪 | 康哲药业 12月15日卖空量成交99.6万股，卖空比例为11.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591649590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591649590?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:30","pubTimestamp":1765787415,"startTime":"0","endTime":"0","summary":"康哲药业北京时间12月15日，跌2.28%，卖空量成交99.6万股，较上一交易日减少68.43%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163151a44d3db1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163151a44d3db1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BVYPNQ40.USD","BK1191","IE00BYV24P56.USD","SG9999015945.SGD","BK1593","IE00BVYPNP33.GBP","00867","SG9999015986.USD","SG9999015978.USD","IE00BMCWC346.EUR","LU2488822045.USD","SG9999015952.SGD","IE00BGHQDM52.EUR","SG9999004220.SGD"],"gpt_icon":0},{"id":"2591962598","title":"每日卖空追踪 | 四环医药 12月15日卖空量成交48.3万股，卖空比例为3.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591962598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591962598?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:30","pubTimestamp":1765787412,"startTime":"0","endTime":"0","summary":"四环医药北京时间12月15日，跌2.29%，卖空量成交48.3万股，较上一交易日减少85.59%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163124a44d3d2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163124a44d3d2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1600","BK1593","00460","BK1191"],"gpt_icon":0},{"id":"2591649596","title":"康哲药业12月15日主力净流出175.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2591649596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591649596?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:15","pubTimestamp":1765786552,"startTime":"0","endTime":"0","summary":"12月15日, 康哲药业股价跌2.28%，报收13.26元，成交金额1.2亿元，换手率0.36%，振幅4.13%，量比1.53。康哲药业今日主力资金净流出175.4万元，上一交易日主力净流入703.9万元。该股近5个交易日下跌2.34%，主力资金累计净流入2930.9万元；近20日主力资金累计净流入6784.1万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215162105a44d30a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215162105a44d30a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015952.SGD","IE00BYV24P56.USD","00867","BK1593","BK1191","IE00BMCWC346.EUR","SG9999015945.SGD","IE00BVYPNP33.GBP","SG9999015978.USD","SG9999015986.USD","SG9999004220.SGD","LU2488822045.USD","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD"],"gpt_icon":0},{"id":"2591936666","title":"智通决策参考︱关注地产和消费端能否找到发力点","url":"https://stock-news.laohu8.com/highlight/detail?id=2591936666","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591936666?lang=zh_cn&edition=full","pubTime":"2025-12-15 09:05","pubTimestamp":1765760744,"startTime":"0","endTime":"0","summary":"国内政策对冲关键在于地产和消费端能否找到发力点。相关个股值得关注。Suisselle成立于2021年，核心产品CELLBOOSTER系列水光针是全球首款获得CE认证的稳定复合型水光针，同步布局三文鱼针剂以及外泌体等细胞治疗产品领域。2，童颜针&少女针产品获批或快速放量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00460","MCHmain","BK1167","513600","01725","02833","BK1515","BK1600","BK1593","BK1191","HHImain","MHImain","BK1211","BK1589","HSI","02357"],"gpt_icon":0},{"id":"2591663764","title":"斥资近4000万押注连亏企业，昊海生科业绩承压下“赌”新赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2591663764","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591663764?lang=zh_cn&edition=full","pubTime":"2025-12-14 18:30","pubTimestamp":1765708205,"startTime":"0","endTime":"0","summary":"继完成对新产业眼科的全资控股后，昊海生科又出手了。更为关键的是，本次交易未设置任何业绩承诺或对赌安排。2024年，昊海生科虽创下营收26.98亿元、归母净利润4.2亿元的历史最佳业绩，但增速已明显乏力，营收与净利润同比仅分别微增1.64%和1.04%。进入2025年，其业绩持续下滑。医药行业分析师朱明军表示，昊海生科并购瑞济生物是业绩承压下的战略补位，生物羊膜赛道的增长潜力与业务协同性值得肯定，但风险同样不容忽视。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214183239a449d95c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214183239a449d95c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","06826"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":-0.0533},{"period":"3month","weight":-0.0306},{"period":"6month","weight":0.0809},{"period":"1year","weight":0.2833},{"period":"ytd","weight":0.2776}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"name":"BK1593","nameEN":"BK1593"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医美概念股(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医美概念股,BK1593,医美概念股股票,医美概念股股票老虎,医美概念股股票老虎国际,医美概念股行情,医美概念股股票行情,医美概念股股价,医美概念股股市,医美概念股股票价格,医美概念股股票交易,医美概念股股票购买,医美概念股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医美概念股(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}